Intellipharmaceutics (IPCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IPCI | CANF | LYRA | ||
| Company | Intellipharmaceutics | Can-Fite Biopharma Ltd ADR | Lyra Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE Arca | NASDAQ | ||
| Open | 0.22 | 4.08 | 2.29 | ||
| High | 0.27 | 4.40 | 2.39 | ||
| Low | 0.21 | 3.98 | 2.27 | ||
| Latest | 0.21 | 4.35 | 2.31 | ||
| Change | -0.06 | +0.27 | +0.06 | ||
| % Change | -22.00% | +6.62% | +2.67% | ||
| Volume | 2,368,700 | 45,096 | 9,612 | ||
| 20-Day Average Volume | 1,022,865 | 566,511 | 121,270 | ||
| Previous Close | 0.27 | 4.08 | 2.25 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.28 | 4.15 | 2.91 | ||
| 20-Day Raw Stochastic | 0.32% | 46.55% | 29.30% | ||
| 20-Day Relative Strength | 37.08 | 41.80 | 36.15 | ||
| Weighted Alpha | -87.59 | -85.36 | -84.52 | ||
| Today's Opinion | 100% Sell | 88% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 48% Sell | 100% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -17.09% since 03/13/19 | +1.17% since 01/14/26 | +22.05% since 01/14/26 | ||
| Low | 0.21 on 03/20/19 | 3.87 on 01/20/26 | 1.89 on 01/16/26 | ||
| High | 0.28 on 03/18/19 | 4.43 on 01/15/26 | 2.58 on 01/20/26 | ||
| 1-Month | |||||
| %Chg | -44.58% since 02/20/19 | -11.32% since 12/22/25 | -36.28% since 12/22/25 | ||
| Low | 0.21 on 03/20/19 | 3.36 on 12/29/25 | 1.63 on 01/12/26 | ||
| High | 0.40 on 02/21/19 | 5.47 on 12/26/25 | 3.94 on 01/09/26 | ||
| 3-Month | |||||
| %Chg | -10.38% since 12/20/18 | -56.52% since 10/22/25 | -64.46% since 10/22/25 | ||
| Low | 0.21 on 03/20/19 | 3.36 on 12/29/25 | 1.63 on 01/12/26 | ||
| High | 0.43 on 02/20/19 | 12.30 on 11/18/25 | 6.72 on 10/23/25 | ||
| 6-Month | |||||
| %Chg | -92.37% since 09/20/18 | -78.83% since 07/22/25 | -71.87% since 07/22/25 | ||
| Low | 0.20 on 12/13/18 | 3.36 on 12/29/25 | 1.63 on 01/12/26 | ||
| High | 4.10 on 09/24/18 | 21.00 on 07/23/25 | 8.75 on 10/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,618 | 5,342 | 3,994 | ||
| Shares Outstanding, K | 21,926 | 1,309 | 1,775 | ||
| Annual Sales | 1,710,000 | 670,000 | 1,530,000 | ||
| Annual Net Income | -13,750,000 | -7,880,000 | -93,440,000 | ||
| Last Quarter Sales | 390,000 | 160,000 | 30,000 | ||
| Last Quarter Net Income | -3,780,000 | -1,650,000 | -5,980,000 | ||
| 60-Month Beta | 2.17 | 1.03 | 0.01 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | -3.38 on 11/12/25 | ||
| Latest Earnings Date | 04/15/19 | 04/13/26 | 03/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||